NCT00046774View on ClinicalTrials.gov

Monoclonal Antibody Treatment for Systemic Lupus Erythematosus

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

September 2, 2002

Primary Completion Date

January 1, 2007

Study Completion Date

September 7, 2017

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

MRA 003 US

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

NCT00046774 - Monoclonal Antibody Treatment for Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter